Jean-Jacques Kiladjian/LinkedIn
Apr 18, 2026, 10:58
Jean Jacques Kiladjian: Honored to Join the HST EHA Session at the Taiwan Annual Meeting
Jean Jacques Kiladjian, Head of Clinical Research Department of Inserm, shared a post on LinkedIn:
“Honored to be invited by the Hematology Society of Taiwan and Taiwan Society of Blood and Marrow Transplantation to participate in the joint HST – European Hematology Association (EHA) session during their annual meeting.
Always a great pleasure to be in Taipei and reconnect with colleagues and friends (for my 6th travel in Taiwan!)”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials